Loss of Interleukin-10 Exacerbates Early Type-1 Diabetes-induced Bone Loss

Overview

Journal J Cell Physiol

Specialties Cell Biology
Physiology

Date 2019 Sep 21

PMID 31538345

Citations 11

Authors

Naiomy D Rios-Arce

Andrew Dagenais

Derrick Feenstra

Brandon Coughlin

Ho Jun Kang

Susanne Mohr

Laura R McCabe

Narayanan Parameswaran

Affiliations

Soon will be listed here.

Abstract

Type-1 diabetes (T1D) increases systemic inflammation, bone loss, and risk for bone fractures. Levels of the anti-inflammatory cytokine interleukin-10 (IL-10) are decreased in T1D, however their role in T1D-induced osteoporosis is unknown. To address this, diabetes was induced in male IL-10 knockout (KO) and wild-type (WT) mice. Analyses of femur and vertebral trabecular bone volume fraction identified bone loss in T1D-WT mice at 4 and 12 weeks, which in T1D-IL-10-KO mice was further reduced at 4 weeks but not 12 weeks. IL-10 deficiency also increased the negative effects of T1D on cortical bone. Osteoblast marker osterix was decreased, while osteoclast markers were unchanged, suggesting that IL-10 promotes anabolic processes. MC3T3-E1 osteoblasts cultured under high glucose conditions displayed a decrease in osterix which was prevented by addition of IL-10. Taken together, our results suggest that IL-10 is important for promoting osteoblast maturation and reducing bone loss during early stages of T1D.

Citing Articles

Type 2 diabetes and bone mineral density: A meta-analysis and systematic review.

Li M, Sun H, Chen H, Ma W, Li Y Medicine (Baltimore). 2024; 103(45):e40468.

PMID: 39533557 PMC: 11557011. DOI: 10.1097/MD.0000000000040468.

Immunologic Aspects in Fibrodysplasia Ossificans Progressiva.

Diolintzi A, Pervin M, Hsiao E Biomolecules. 2024; 14(3).

PMID: 38540775 PMC: 10967946. DOI: 10.3390/biom14030357.

Insights and implications of sexual dimorphism in osteoporosis.

Zhang Y, Xie N, Sun X, Nice E, Liou Y, Huang C Bone Res. 2024; 12(1):8.

PMID: 38368422 PMC: 10874461. DOI: 10.1038/s41413-023-00306-4.

Trabecular bone score in type 1 diabetes: a meta-analysis of cross-sectional studies.

Pan R, Zhang Y, Zhao Y J Orthop Surg Res. 2023; 18(1):794.

PMID: 37875949 PMC: 10594696. DOI: 10.1186/s13018-023-04289-0.

AR/PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes-related osteoporosis by activating Nrf2/Keap1 pathway.

Fu F, Luo H, Du Y, Chen Y, Tian K, Pan J J Cell Mol Med. 2023; 27(22):3601-3613.

PMID: 37621124 PMC: 10660633. DOI: 10.1111/jcmm.17928.

References

Kim Y, Pyo S . Interleukin-10 suppresses adipogenesis via Wnt5a signaling pathway in 3T3-L1 preadipocytes. Biochem Biophys Res Commun. 2019; 509(4):877-885. DOI: 10.1016/j.bbrc.2019.01.033. View

Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W . Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care. 2005; 28(12):2850-5. DOI: 10.2337/diacare.28.12.2850. View

Shah V, Shah C, Snell-Bergeon J . Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015; 32(9):1134-42. PMC: 4860902. DOI: 10.1111/dme.12734. View

Sinha K, Zhou X . Genetic and molecular control of osterix in skeletal formation. J Cell Biochem. 2012; 114(5):975-84. PMC: 3725781. DOI: 10.1002/jcb.24439. View

Zayzafoon M, Botolin S, McCabe L . P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem. 2002; 277(40):37212-8. DOI: 10.1074/jbc.M200129200. View

Shan T, Liu W, Kuang S . Fatty acid binding protein 4 expression marks a population of adipocyte progenitors in white and brown adipose tissues. FASEB J. 2012; 27(1):277-87. PMC: 3528316. DOI: 10.1096/fj.12-211516. View

Strotmeyer E, Cauley J, Schwartz A, Nevitt M, Resnick H, Zmuda J . Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res. 2004; 19(7):1084-91. DOI: 10.1359/JBMR.040311. View

Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A . Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000; 275(7):4858-64. DOI: 10.1074/jbc.275.7.4858. View

Zhang Q, Chen B, Yan F, Guo J, Zhu X, Ma S . Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases. Biomed Res Int. 2014; 2014:284836. PMC: 3947664. DOI: 10.1155/2014/284836. View

10.

Al-Rasheed A, Scheerens H, Rennick D, Fletcher H, Tatakis D . Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res. 2003; 82(8):632-5. DOI: 10.1177/154405910308200812. View

11.

Motyl K, Botolin S, Irwin R, Appledorn D, Kadakia T, Amalfitano A . Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol. 2008; 218(3):575-83. DOI: 10.1002/jcp.21626. View

12.

Al-Rasheed A, Scheerens H, Srivastava A, Rennick D, Tatakis D . Accelerated alveolar bone loss in mice lacking interleukin-10: late onset. J Periodontal Res. 2004; 39(3):194-8. DOI: 10.1111/j.1600-0765.2004.00724.x. View

13.

Xu L, Kukita T, Kukita A, Otsuka T, Niho Y, Iijima T . Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system. J Cell Physiol. 1995; 165(3):624-9. DOI: 10.1002/jcp.1041650321. View

14.

Coe L, Tekalur S, Shu Y, Baumann M, McCabe L . Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. J Cell Physiol. 2015; 230(8):1944-53. PMC: 4724196. DOI: 10.1002/jcp.24929. View

15.

Verhaeghe J, Thomsen J, Van Bree R, Van Herck E, Bouillon R, Mosekilde L . Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone. 2000; 27(2):249-56. DOI: 10.1016/s8756-3282(00)00308-2. View

16.

Snell-Bergeon J, West N, Mayer-Davis E, Liese A, Marcovina S, DAgostino Jr R . Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study. J Clin Endocrinol Metab. 2010; 95(6):2868-76. PMC: 2902077. DOI: 10.1210/jc.2009-1993. View

17.

Bonds D, Larson J, Schwartz A, Strotmeyer E, Robbins J, Rodriguez B . Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006; 91(9):3404-10. DOI: 10.1210/jc.2006-0614. View

18.

Pereira L, Font-Nieves M, Van den Haute C, Baekelandt V, Planas A, Pozas E . IL-10 regulates adult neurogenesis by modulating ERK and STAT3 activity. Front Cell Neurosci. 2015; 9:57. PMC: 4340210. DOI: 10.3389/fncel.2015.00057. View

19.

Chiang C, Kyritsis G, Graves D, Amar S . Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun. 1999; 67(8):4231-6. PMC: 96729. DOI: 10.1128/IAI.67.8.4231-4236.1999. View

20.

Rennick D, Fort M . Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2000; 278(6):G829-33. DOI: 10.1152/ajpgi.2000.278.6.G829. View